All Stories

UK's Epsilogen acquires fellow immunoglobin biotech TigaTx to boost cancer antibody options

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer antibody company.”

Apr 7, 2025 - 13:58
 0
UK's Epsilogen acquires fellow immunoglobin biotech TigaTx to boost cancer antibody options
U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer antibody company.”
Read More

Tags:

Previous Article

2026 Mercedes-AMG C63 to drop PHEV four for new PHEV six

Next Article

Cell-cultured mouse ‘mousse’ petfood headed for commercial release

Related Posts

BridgeBio's KRAS-focused cancer spinout backs SPAC as path to Nasdaq

BridgeBio's KRAS-focused cancer spinout backs SPAC as p...

Feb 28, 2025  0

Vaxart lays off 10% of staff after HHS unexpectedly demands halt to COVID vaccine trial

Vaxart lays off 10% of staff after HHS unexpectedly dem...

Mar 21, 2025  0

Chutes & Ladders—Former FDA deputy joins AI biotech's board

Chutes & Ladders—Former FDA deputy joins AI biotech's b...

Mar 21, 2025  0